<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2022-16-6-130-136</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-6822</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>GYNECOLOGY</subject></subj-group></article-categories><title-group><article-title>Исходы беременности и заболевания щитовидной железы: оценка риска преждевременных родов</article-title><trans-title-group xml:lang="en"><trans-title>Pregnancy outcomes and thyroid dysfunction: preterm birth risk assessment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2612-7339</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Матейкович</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mateykovich</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры акушерства и гинекологии лечебного факультета, 625023, Тюмень, ул. Одесская, д. 54; </p><p>врач – акушер-гинеколог, 625002, Тюмень, ул. Даудельная, д. 1</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Associate Professor of the Department of Obstetrics and Gynecology of the Medical Faculty, 54, Odesskaya St., Tyumen, 625023;</p><p>Obstetrician-Gynecologist, 1, Daudelnaya St., Tyumen, 625002</p></bio><email xlink:type="simple">mat-maxim@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9472-1233</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернова</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernova</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доцент кафедры акушерства и гинекологии лечебного факультета, </p><p>625023, Тюмень, ул. Одесская, д. 54</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Associate Professor of the Department of Obstetrics and Gynecology of the Medical Faculty, </p><p>54, Odesskaya St., Tyumen, 625023</p></bio><email xlink:type="simple">chern_igor@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7019-6630</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шевлюкова</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Shevlyukova</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры акушерства и гинекологии лечебного факультета, </p><p>625023, Тюмень, ул. Одесская, д. 54</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor of the Department of Obstetrics and Gynecology of the Medical Faculty, </p><p>54, Odesskaya St., Tyumen, 625023</p></bio><email xlink:type="simple">tata21.01@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9092-9136</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суханов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sukhanov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ассистент кафедры акушерства и гинекологии лечебного факультета, 625023, Тюмень, ул. Одесская, д. 54;</p><p>к.м.н., заведующий отделением планирования семьи и репродукции, 625002, Тюмень, ул. Даудельная, д. 1</p></bio><bio xml:lang="en"><p>Assistant of the Department of Obstetrics and Gynecology of the Medical Faculty, 54, Odesskaya St., Tyumen, 625023;</p><p>Cand. Sci. (Med.), Head of the Department of Family Planning and Reproduction, 1, Daudelnaya St., Tyumen, 625002</p></bio><email xlink:type="simple">perinatal@med-to.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Тюменский государственный медицинский университет; &#13;
Перинатальный центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tyumen State Medical University; &#13;
Perinatal Medical Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Тюменский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tyumen State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Тюменский государственный медицинский университет;&#13;
Перинатальный центр</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Perinatal Medical Center; &#13;
Tyumen State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>25</day><month>04</month><year>2022</year></pub-date><volume>0</volume><issue>6</issue><fpage>130</fpage><lpage>136</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Матейкович Е.А., Чернова А.Л., Шевлюкова Т.П., Суханов А.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Матейкович Е.А., Чернова А.Л., Шевлюкова Т.П., Суханов А.А.</copyright-holder><copyright-holder xml:lang="en">Mateykovich E.A., Chernova A.L., Shevlyukova T.P., Sukhanov A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/6822">https://www.med-sovet.pro/jour/article/view/6822</self-uri><abstract><sec><title>Введение</title><p>Введение. Субклинический гипотиреоз встречается у 2–3% беременных и часто ассоциируется с осложнениями беременности, включая преждевременные роды.</p><p>Цель – изучить корреляционные связи между дисфункцией щитовидной железы и исходами беременности и родов.</p></sec><sec><title>Материалы и  методы</title><p>Материалы и  методы. Проанализированы 64  клинических случая ведения беременных в  Перинатальном центре  (Тюмень) за 2017–2021 гг.: 28 женщин с тиреотропным гормоном (ТТГ) &gt; 2,5 мЕд/л, 36 женщин с ТТГ ≤ 2,5 мЕд/л в течение всего периода беременности. Количественные признаки описаны абсолютными и относительными (процентами) показателями. Вероятность исхода в зависимости от наличия клинико-амнестического фактора оценивалась путем определения относительного риска (RR) и 95%-го доверительного интервала (CI). Уровень статистической значимости при проверке нулевой гипотезы – р &lt; 0,05. Результаты. Не  выявлено различий у  беременных с  субклиническим гипотиреозом и  без него при рассмотрении таких медико-социальных факторов, как возраст, семейное положение, работа, образование, никотиновая зависимость, ожирение, заболевания почек. Выявлен повышенный риск преждевременных родов у  пациенток с  уровнем ТТГ  &gt;  2,5  мЕд/л: RR 1,41 (0,59–3,37), особенно на фоне положительного теста на антитела к тиреопероксидазе: RR 1,63 (0,62–4,28). При отсутствии лечения выявлен риск раннего срока родоразрешения, преждевременных родов, преэклампсии.</p></sec><sec><title>Выводы</title><p>Выводы. Универсальный подход к  определению пороговых значений ТТГ для диагностики субклинического гипотиреоза у беременных, к необходимости и тактике его лечения не выработан. Заболевания щитовидной железы являются эндемическими для Западной Сибири, часто ассоциируются с железодефицитной анемией, отмечается их высокая частота в анамнезе беременных. Установление корреляции субклинического гипотиреоза, проведенной гормональной коррекции и осложнений беременности требует проведения дальнейших исследований. Препятствием является отсутствие надлежащей диагностики уровня ТТГ у женщин, родоразрешаемых в экстренном порядке в ранние гестационные сроки. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Subclinical hypothyroidism occurs in 2–3% of pregnant women and is often associated with pregnancy complications, including preterm birth.</p><p>Aim – to study correlations between thyroid dysfunction and pregnancy outcomes.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 64 clinical cases of managing pregnant women in the Perinatal Center (Tyumen) were analyzed for 2017– 2021: 28 women with thyroid-stimulating hormone (TSH) &gt; 2.5 mU/l, 36 women with TSH ≤ 2.5 mU/l) during the entire period of pregnancy. Quantitative features are described by absolute and relative (percentage) indicators. The probability of outcome depending on the presence of a clinical-amnestic factor was assessed by determining the relative risk (RR) and 95% confidence interval (CI). The level of statistical significance in testing the null hypothesis is p &lt; 0.05.</p></sec><sec><title>Results</title><p>Results. There were no differences in pregnant women with and without subclinical hypothyroidism when considering such medical and social factors as age, marital status, work, education, nicotine addiction, obesity, kidney disease. An increased risk of preterm delivery was found in patients with a TSH level &gt; 2.5 mU/l: RR 1.41 (0.59–3.37), especially against the background of a positive test for antibodies to thyroperoxidase: RR 1.63 (0.62–4.28). In the absence of treatment, the risk of early delivery, preterm birth, preeclampsia was revealed.</p></sec><sec><title>Conclusions</title><p>Conclusions. A universal approach to determining the threshold values of TSH for the diagnosis of subclinical hypothyroidism in pregnant women, to the need and tactics of its treatment has not been developed. Diseases of the thyroid gland are endemic for Western Siberia, often associated with iron deficiency anemia, their high frequency in the anamnesis of pregnant women is  noted. Establishing a  correlation between subclinical hypothyroidism, hormonal correction and pregnancy complications requires further research. An obstacle is the lack of proper diagnosis of the TSH level in women who give birth on an emergency basis in early gestational periods. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>беременность</kwd><kwd>щитовидная железа</kwd><kwd>субклинический гипотиреоз</kwd><kwd>преждевременные роды</kwd><kwd>тиреотропный гормон</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pregnancy</kwd><kwd>thyroid gland</kwd><kwd>subclinical hypothyroidism</kwd><kwd>preterm birth</kwd><kwd>thyroid-stimulating hormone</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rysavy M.A., Li L., Bell E.F., Das A., Hintz S.R., Stoll B.J. et al. Betweenhospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med. 2015;372(19):1801–1811. https://doi.org/10.1056/nejmoa1410689.</mixed-citation><mixed-citation xml:lang="en">Rysavy M.A., Li L., Bell E.F., Das A., Hintz S.R., Stoll B.J. et al. Betweenhospital variation in treatment and outcomes in extremely preterm infants. N Engl J Med. 2015;372(19):1801–1811. https://doi.org/10.1056/nejmoa1410689.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Радзинский В.Е., Хамошина М.Б., Тулупова М.С., Дамирова К.Ф., Рамазанова Ф.У., Каушанская Л.В. Прогестерон: спорные вопросы терапии и профилактики невынашивания и недонашивания беременности. Акушерство и гинекология: новости, мнения, обучение. 2019;7(3 Прил.):74–82. https://doi.org/10.24411/2303-9698-2019-13910.</mixed-citation><mixed-citation xml:lang="en">Radzinskiy V.E., Khamoshina M.B., Tulupova M.S., Damirova K.F., Ramazanova F.U., Kaushanskaya L.V. Progesteron: disputable issues of therapy and prevention of prematurity and preterm birth. Akusherstvo i Ginekologiya: Novosti, Mneniya, Obuchenie. 2019;7(3 Suppl.): 74–82. (In Russ.) https://doi.org/10.24411/2303-9698-2019-13910.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Сидельникова В.М. Привычная потеря беременности. М.: Триада-Х; 2005. 304 с.</mixed-citation><mixed-citation xml:lang="en">Sidelnikova V.M. Habitual pregnancy loss. Moscow: Triada-X; 2005. 304 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Полушкина Е.С., Шмаков Р.Г. Роль дидрогестерона в привычном невынашивании беременности. Медицинский совет. 2020;(3):74–77. https://doi.org/10.21518/2079-701X-2020-3-74-77.</mixed-citation><mixed-citation xml:lang="en">Polushkina E.S., Shmakov R.G. The role of dydrogesterone in habitual miscarriage. Meditsinskiy Sovet. 2020;(3):74–77. (In Russ.) https://doi.org/10.21518/2079-701X-2020-3-74-77.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ушанова Ф.О., Лобанова К.Г., Переходов С.Н. Гестационный сахарный диабет: особенности течения и исходы беременности в реальной клинической практике. Медицинский совет. 2021;(7):184–191. https://doi.org/10.21518/2079-701X-2021-7-184-191.</mixed-citation><mixed-citation xml:lang="en">Ushanova F.O., Lobanova K.G., Perekhodov S.N. Gestational diabetes mellitus: peculiarities of course and pregnancy outcomes in real clinical practice. Meditsinskiy Sovet. 2021;(7):184–191. (In Russ.) https://doi.org/10.21518/2079-701X-2021-7-184-191.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., Wang H., Pan X., Teng W., Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis. PLoS ONE. 2017;12(4):e0175708. https://doi.org/10.1371/journal.pone.0175708.</mixed-citation><mixed-citation xml:lang="en">Zhang Y., Wang H., Pan X., Teng W., Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: A systematic review and meta-analysis. PLoS ONE. 2017;12(4):e0175708. https://doi.org/10.1371/journal.pone.0175708.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ding Z., Liu Y., Maraka S., Abdelouahab N., Huang H.F., Fraser W.D., Fan J. Pregnancy and Neonatal Outcomes With Levothyroxine Treatment in Women With Subclinical Hypothyroidism Based on New Diagnostic Criteria: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021;12:797423. https://doi.org/10.3389/fendo.2021.797423.</mixed-citation><mixed-citation xml:lang="en">Ding Z., Liu Y., Maraka S., Abdelouahab N., Huang H.F., Fraser W.D., Fan J. Pregnancy and Neonatal Outcomes With Levothyroxine Treatment in Women With Subclinical Hypothyroidism Based on New Diagnostic Criteria: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021;12:797423. https://doi.org/10.3389/fendo.2021.797423.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Peeters R.P. Subclinical Hypothyroidism. N Engl J Med. 2017;376(26): 2556–2565. https://doi.org/10.1056/NEJMcp1611144.</mixed-citation><mixed-citation xml:lang="en">Peeters R.P. Subclinical Hypothyroidism. N Engl J Med. 2017;376(26): 2556–2565. https://doi.org/10.1056/NEJMcp1611144.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">So S., Tawara F. Risk factors of subclinical hypothyroidism and the potential contribution to miscarriage: A review. Reprod Med Biol. 2020;19(3):232–242. https://doi.org/10.1002/rmb2.12325.</mixed-citation><mixed-citation xml:lang="en">So S., Tawara F. Risk factors of subclinical hypothyroidism and the potential contribution to miscarriage: A review. Reprod Med Biol. 2020;19(3):232–242. https://doi.org/10.1002/rmb2.12325.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Negro R., Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ. 2014;349:g4929. https://doi.org/10.1136/bmj.g4929.</mixed-citation><mixed-citation xml:lang="en">Negro R., Stagnaro-Green A. Diagnosis and management of subclinical hypothyroidism in pregnancy. BMJ. 2014;349:g4929. https://doi.org/10.1136/bmj.g4929.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Li M., He Y., Mao Y., Yang L., Chen L., Du J. et al. Preconception thyroidstimulating hormone levels and adverse pregnancy outcomes. Clin Endocrinol (Oxf). 2021. https://doi.org/10.1111/cen.14668.</mixed-citation><mixed-citation xml:lang="en">Li M., He Y., Mao Y., Yang L., Chen L., Du J. et al. Preconception thyroidstimulating hormone levels and adverse pregnancy outcomes. Clin Endocrinol (Oxf). 2021. https://doi.org/10.1111/cen.14668.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kiran Z., Sheikh A., Humayun K.N., Islam N. Neonatal outcomes and congenital anomalies in pregnancies affected by hypothyroidism. Ann Med. 2021;53(1):1560–1568. https://doi.org/10.1080/07853890.2021.1970798.</mixed-citation><mixed-citation xml:lang="en">Kiran Z., Sheikh A., Humayun K.N., Islam N. Neonatal outcomes and congenital anomalies in pregnancies affected by hypothyroidism. Ann Med. 2021;53(1):1560–1568. https://doi.org/10.1080/07853890.2021.1970798.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Xu Y., Sun Z., Cai Y., Wang B., Zhang M. et al. Differential lipids in pregnant women with subclinical hypothyroidism and their correlation to the pregnancy outcomes. Sci Rep. 2021;11(1):19689. https://doi.org/10.1038/s41598-021-99252-6.</mixed-citation><mixed-citation xml:lang="en">Li J., Xu Y., Sun Z., Cai Y., Wang B., Zhang M. et al. Differential lipids in pregnant women with subclinical hypothyroidism and their correlation to the pregnancy outcomes. Sci Rep. 2021;11(1):19689. https://doi.org/10.1038/s41598-021-99252-6.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.Y., Pearce E.N. Testing, Monitoring, and Treatment of Thyroid Dysfunction in Pregnancy. J Clin Endocrinol Metab. 2021;106(3):883–892. https://doi.org/10.1210/clinem/dgaa945.</mixed-citation><mixed-citation xml:lang="en">Lee S.Y., Pearce E.N. Testing, Monitoring, and Treatment of Thyroid Dysfunction in Pregnancy. J Clin Endocrinol Metab. 2021;106(3):883–892. https://doi.org/10.1210/clinem/dgaa945.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Biondi B., Kahaly G.J., Robertson R.P. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019;40(3): 789–824. https://doi.org/10.1210/er.2018-00163.</mixed-citation><mixed-citation xml:lang="en">Biondi B., Kahaly G.J., Robertson R.P. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019;40(3): 789–824. https://doi.org/10.1210/er.2018-00163.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Calina D., Docea A.O., Petrakis D., Egorov A.M., Ishmukhametov A.A., Gabibov A.G. et al. Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med. 2020;46(1):3–16. https://doi.org/10.3892/ijmm.2020.4596.</mixed-citation><mixed-citation xml:lang="en">Calina D., Docea A.O., Petrakis D., Egorov A.M., Ishmukhametov A.A., Gabibov A.G. et al. Towards effective COVID-19 vaccines: Updates, perspectives and challenges (Review). Int J Mol Med. 2020;46(1):3–16. https://doi.org/10.3892/ijmm.2020.4596.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bekkar B., Pacheco S., Basu R., DeNicola N. Association of Air Pollution and Heat Exposure With Preterm Birth, Low Birth Weight, and Stillbirth in the US: A Systematic Review. JAMA Netw Open. 2020;3(6):e208243. https://doi.org/10.1001/jamanetworkopen.2020.8243.</mixed-citation><mixed-citation xml:lang="en">Bekkar B., Pacheco S., Basu R., DeNicola N. Association of Air Pollution and Heat Exposure With Preterm Birth, Low Birth Weight, and Stillbirth in the US: A Systematic Review. JAMA Netw Open. 2020;3(6):e208243. https://doi.org/10.1001/jamanetworkopen.2020.8243.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Суплотова Л.А., Макарова О.Б., Ковальжина Л.С. Неонатальная гипертиреотропинемия – индикатор оценки тяжести йодного дефицита в популяции? Клиническая и экспериментальная тиреоидология. 2015;11(3):47-53. https://doi.org/10.14341/ket2015347-53.</mixed-citation><mixed-citation xml:lang="en">Suplotova L.A., Makarova O.B., Kovalzhina L.S. Neonatal gipertireotropinemiya – an indicator of the severity of iodine deficiency in the population? Clinical and Experimental Thyroidology. 2015;11(3): 47–53. (In Russ.) https://doi.org/10.14341/ket2015347-53.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Negro R. Outcomes in Pregnant Patients with Subclinical Hypothyroidism and Thyroid Autoimmunity: A Critical Appraisal of Recent Randomized Controlled Trials. Endocr Metab Immune Disord Drug Targets. 2021;21(8):1387–1391. https://doi.org/10.2174/1871530320999201116200153.</mixed-citation><mixed-citation xml:lang="en">Negro R. Outcomes in Pregnant Patients with Subclinical Hypothyroidism and Thyroid Autoimmunity: A Critical Appraisal of Recent Randomized Controlled Trials. Endocr Metab Immune Disord Drug Targets. 2021;21(8):1387–1391. https://doi.org/10.2174/1871530320999201116200153.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Матейкович Е.А., Кукарская И.И., Легалова Т.В. Клинико-статистическая оценка репродуктивного здоровья женщин фертильного возраста Тюменской области и риски невынашивания беременности в условиях Западной Сибири. Медицинский совет. 2021;(21–1):198–204. https://doi.org/10.21518/2079-701X-2021-21-1-198-204.</mixed-citation><mixed-citation xml:lang="en">Mateykovich E.A., Kukarskaya I.I., Legalova T.V. Clinical and statistical assessment of the reproductive health of fertilized women in the Tyumen region and the risks of miscarriage in Western Siberia. Meditsinskiy Sovet. 2021;(21–1):198–204. (In Russ.) https://doi.org/10.21518/2079- 701X-2021-21-1-198-204.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Morchiladze N., Tkeshelashvili B., Gagua T., Gagua D. Prognostic risk of obstetric and perinatal complications in pregnant women with thyroid dysfunction. Georgian Med News. 2017;(264):21–25. Available at: https://pubmed.ncbi.nlm.nih.gov/28480843/.</mixed-citation><mixed-citation xml:lang="en">Morchiladze N., Tkeshelashvili B., Gagua T., Gagua D. Prognostic risk of obstetric and perinatal complications in pregnant women with thyroid dysfunction. Georgian Med News. 2017;(264):21–25. Available at: https://pubmed.ncbi.nlm.nih.gov/28480843/.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Li C., Shan Z., Mao J., Wang W., Xie X., Zhou W. et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73–79. https://doi.org/10.1210/jc.2013-1674.</mixed-citation><mixed-citation xml:lang="en">Li C., Shan Z., Mao J., Wang W., Xie X., Zhou W. et al. Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 2014;99(1):73–79. https://doi.org/10.1210/jc.2013-1674.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gietka-Czernel M., Glinicki P. Subclinical hypothyroidism in pregnancy: controversies on diagnosis and treatment. Pol Arch Intern Med. 2021;131(3):266–275. https://doi.org/10.20452/pamw.15626.</mixed-citation><mixed-citation xml:lang="en">Gietka-Czernel M., Glinicki P. Subclinical hypothyroidism in pregnancy: controversies on diagnosis and treatment. Pol Arch Intern Med. 2021;131(3):266–275. https://doi.org/10.20452/pamw.15626.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.Y., Pearce E.N. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol. 2022;18(3):158–171. https://doi.org/10.1038/s41574-021-00604-z.</mixed-citation><mixed-citation xml:lang="en">Lee S.Y., Pearce E.N. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol. 2022;18(3):158–171. https://doi.org/10.1038/s41574-021-00604-z.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshihara H., Sugiura-Ogasawara M., Goto S., Kitaori T. Levothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss. Am J Reprod Immunol. 2021;85(3):e13341. https://doi.org/10.1111/aji.13341.</mixed-citation><mixed-citation xml:lang="en">Yoshihara H., Sugiura-Ogasawara M., Goto S., Kitaori T. Levothyroxine and subclinical hypothyroidism in patients with recurrent pregnancy loss. Am J Reprod Immunol. 2021;85(3):e13341. https://doi.org/10.1111/aji.13341.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
